Patient safety has taken on an urgency and this focus has forced massive technological advancements in pharmacovigilance. It is crucial and imperative to modernize the clinical trial process, introduce federated machine learning systems, employ artificial intelligence in safety systems, and ensure real-time PV reporting.
With technology adoption, processing time for case intake in pharmacovigilance is exponentially faster. Automating testing cycles brings forth an opportunity to formulate faster hypotheses and expedite adverse events. It improves the drug's Risk-Benefit Profile that further enhances safety standards. It also reduces repetitive activities like duplicate searches of cases and reporting.
Visit our Life Sciences & Healthcare page
The spread of Covid-19 challenged traditional clinical trial models. There was a shift towards patient-centered clinical trial designs, rewriting PV protocols to allow remote patient monitoring and in-home delivery. Further, implementing other digital capabilities, concepts like telemedicine kept clinical research viable.